The role of telomerase activity in psoriatic skin lesions

Medical Hypotheses

Volumn 68, Issue 5, 2007, Pages 1093-1095

  Jurisic, Davor ^a   Kirin, Ivan ^a   Rabic, Domagoj ^b   Dojcinovic, Bojan ^c   Coklo, Miran ^d   Zamolo, Gordana ^d  

^a KBC RIJEKA   (Croatia)

^b Klinika za traumatologiju Zagreb   (Croatia)

^c University of Zagreb School of Medicine   (Croatia)

^d UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TELOMERASE;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; RELIABILITY; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TELOMERE;

APOPTOSIS; CELL PROLIFERATION; HUMANS; KERATINOCYTES; MODELS, BIOLOGICAL; PSORIASIS; TELOMERASE; TELOMERE;

EID: 33847032079     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.09.037     Document Type: Article

References (11)

1. Baran W., Szepietowski J.C., and Szybejko-Machaj G. Expression of p53 protein in psoriasis. Acta Dermatoven APA 14 3 (2005) 79-83
2. Wu K., Higashi N., Hansen E.R., Lund M., Bang K., and Thestrup-Pedersen K. Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol 165 8 (2000) 4742-4747
3. Calado R.T., and Chen J. Telomerase: not just for the elongation of telomeres. Bioessays 28 2 (2006) 109-112
4. Collins K., and Mitchell J.R. Telomerase in the human organism. Oncogene 21 4 (2002) 564-579
5. Uziel O., Fenig E., Nordenberg J., et al. Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines. Br J Cancer 92 10 (2005) 1881-1891
6. Jang H.S., Oh C.K., Jo J.H., Kim Y.S., and Kwon K.S. Detection of telomerase activity in psoriasis lesional skin and correlation with Ki-67 expression and suppression by retinoic acid. J Korean Med Sci 16 5 (2001) 623-629
7. Taylor R.S., Ramirez R.D., Ogoshi M., Chaffins M., Piatyszek M.A., and Shay J.W. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 106 4 (1996) 759-765
8. Ren J.G., Xia H.L., Tian Y.M., Just T., Cai G.P., and Dai Y.R. Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett 488 3 (2001) 133-138
9. Slater M., Scolyer R.A., Gidley-Baird A., Thompson J.F., and Barden J.A. Increased expression of apoptotic markers in melanoma. Melanoma Res 13 2 (2003) 137-145
10. Nickoloff B.J. Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediated skin disease. Viewpoint. J Cutan Pathol 28 2 (2001) 57-64
11. Kastelan M., Prpic Massari L., Gruber F., Zamolo G., Zauhar G., Coklo M., and Rukavina D. Perforin expression is upregulated in the epidermis of psoriatic lesions. Br J Dermatol 151 4 (2004) 831-836